Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
about
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Ofatumumab Plus Bendamustine i ...... ic Lymphocytic Leukaemia (CLL)
@en
type
label
Ofatumumab Plus Bendamustine i ...... ic Lymphocytic Leukaemia (CLL)
@en
prefLabel
Ofatumumab Plus Bendamustine i ...... ic Lymphocytic Leukaemia (CLL)
@en
P17
P1050
P1476
A Phase II, Multi-centre Study ...... ic Lymphocytic Leukaemia (CLL)
@en
P3098
NCT01520922
P580
2012-03-01T00:00:00Z
P582
2013-02-01T00:00:00Z